Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1426 to 1450 of 2529

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Reslizumab for treating severe eosinophilic asthmaTA479
Thora-3Di for assessing asthma in childrenMIB122
Memokath-028, 044 and 045 stents for urethral obstructionMIB123
FreeStyle Libre for glucose monitoringMIB110
Faltering growth: recognition and management of faltering growth in childrenNG75
Intramuscular diaphragm stimulation for ventilator-dependent chronic respiratory failure caused by motor neurone diseaseHTG450
Cetuximab and panitumumab for previously untreated metastatic colorectal cancerTA439
Intermediate care including reablementNG74
Caris Molecular Intelligence for guiding cancer treatmentMIB120
Type 2 diabetes: prevention in people at high riskPH38
Aptiva for painful diabetic neuropathyMIB119
High-intensity focused ultrasound for symptomatic breast fibroadenomaHTG449
Ab externo canaloplasty for primary open-angle glaucomaHTG448
Transition between inpatient mental health settings and community or care home settingsQS159
End of life care for infants, children and young peopleQS160
Pembrolizumab for treating PD-L1-positive non-small-cell lung cancer after chemotherapyTA428
Pembrolizumab for treating advanced melanoma after disease progression with ipilimumabTA357
Pembrolizumab for advanced melanoma not previously treated with ipilimumabTA366
Physical health of people in prisonsQS156
HIV testing: encouraging uptakeQS157
Rehabilitation after critical illness in adultsQS158
Fertility problems: assessment and treatmentCG156
Sorafenib for treating advanced hepatocellular carcinomaTA474
Dimethyl fumarate for treating moderate to severe plaque psoriasisTA475
Paclitaxel as albumin-bound nanoparticles with gemcitabine for untreated metastatic pancreatic cancerTA476

Results per page

  1. 10
  2. 25
  3. 50
  4. All